Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0598934 (
tumor growth
)
58,965
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The long non-coding (lnc)RNA pre-ribosomal RNA antisense transcripts (
PAPAS
) can repress ribosomal RNA synthesis, although its role in human disease is currently unknown. The present study aimed to investigate the function of
PAPAS
in papillary thyroid carcinoma (PTC).
PAPAS
was downregulated, while the lncRNA HOXA transcript at the distal tip (HOTTIP) was upregulated in patients with PTC.
PAPAS
and HOTTIP were inversely associated in PTC.
PAPAS
overexpression led to the downregulation of HOTTIP in PTC cells, while
PAPAS
expression was not significantly affected by HOTTIP overexpression, suggesting that
PAPAS
was upstream of HOTTIP.
PAPAS
expression level decreased, while HOTTIP expression level increased with the increase of clinical staging.
PAPAS
overexpression led to the inhibition of cell proliferation, while HOTTIP overexpression increased proliferation of PTC cells, and HOTTIP overexpression decreased the effects of
PAPAS
overexpression. lncRNA
PAPAS
overexpression may inhibit
tumor growth
in papillary thyroid carcinoma by downregulating lncRNA HOTTIP.
...
PMID:Long non-coding (lnc)RNA PAPAS overexpression inhibits tumor growth in papillary thyroid carcinoma by downregulating lncRNA HOTTIP. 3219 27